Although the traditional M1 and M2 classifications are considered to be related to the prognosis of patients with gliomas, recent single-cell sequencing revealed that glioma-associated macrophages can be further classified more precisely, such as AIF1+TAMs, SPP1+TAMs and CCL3+TAMs49. Here, AIF1 is linked to central nervous system cancer.